Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • CORRESPONDENCE

Industry is more alarmed about reproducibility than academia

  1. Anton Bespalov

    1. Heidelberg, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Adrian G. Barnett

    1. Queensland University of Technology, Brisbane, Australia.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  3. C. Glenn Begley

    1. BioCurate, Melbourne, Australia.

    View author publications

    You can also search for this author in PubMed  Google Scholar

The reproducibility crisis in biomedical science seems to have alarmed industry more than the academic community (see C. G. Begley and L. M. Ellis Nature 483, 531–533; 2012). In our view, this is because they have different yardsticks for success in research.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Nature 563, 626 (2018)

doi: https://doi.org/10.1038/d41586-018-07549-w

Competing Interests

Anton Bespalov is co-founder and managing partner at the Partnership for Assessment and Accreditation of Scientific Practics and co-founder, managing director and chief scientific officer at Exciva. C. Glenn Begley is an employee at BioCurate, a shareholder in Amgen, Akriviea and Tetralogic and an ad hoc consultant to biotech companies.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links